Medicine
Vabomere 1 g/1 g per 2 g powder for injection
Vabomere 1 g/1 g per 2 g powder for injection is a prescription medicine containing Meropenem and Vaborbactam for intravenous use, marketed by Melinta Therapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store VABOMERE vials at 20°C to 25°C (68°F to 77°F), excursions are permitted…
Key facts
- Active ingredient (INN)
- Meropenem and Vaborbactam
- Brand
- Vabomere
- Strength
- 1 g/1 g per 2 g
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 6 vials
- Marketing authorisation holder
- Melinta Therapeutics
- Manufacturer
- Melinta Therapeutics
- Origin register
- US FDA, United States
- Storage
- Store VABOMERE vials at 20°C to 25°C (68°F to 77°F), excursions are permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DH52 Meropenem and Vaborbactam
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 October 2017
- Identifiers
- RxCUI 1945218, 1946651DailyMed set ID e237fd0f-3050-42a3-b43e-b6fb4824e93dNDC 70842-120Application NDA209776
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 6 vial, single-dose in 1 carton / 2 g in 1 vial, single-dose | 70842-120-06 | Melinta Therapeutics | 2 October 2017 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Clinical summary
Meropenem and Vaborbactam is a fixed-dose combination of a penem antibacterial and a beta lactamase inhibitor. It is available as powder for injection for intravenous use. MedsAcross supplies Meropenem and Vaborbactam for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Meropenem and VaborbactamFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- VABOMERE prescribing information (Melinta Therapeutics) · U.S. National Library of Medicine, DailyMed
- Vaborem: European public assessment report (EPAR) · European Medicines Agency
Need Vabomere 1 g/1 g per 2 g powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.